Lucas, MarÃa D López |
Enhancer, NCT05809830: Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas |
|
|
| Recruiting | 1/2 | 152 | Europe | LB-100 plus Doxorrubicin, Doxorubicin | Grupo Espanol de Investigacion en Sarcomas | Advanced Soft-tissue Sarcoma | 06/25 | 05/26 | | |
Fernández, Luis |
BioIBD, NCT03885713: Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease |
|
|
| Recruiting | 4 | 180 | Europe | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 12/24 | 12/24 | | |
NCT03763604: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer |
|
|
| Approved for marketing | N/A | | Europe, Canada, RoW | Abemaciclib, LY2835219 | Eli Lilly and Company | Metastatic Breast Cancer | | | | |
| Recruiting | N/A | 120 | Europe | Endologix Ovation Alto Endograft | DGM Vascular, Hospital Universitario Central de Asturias | Abdominal Aortic Aneurysm | 01/24 | 01/27 | | |
Sola, Luis Fernández |
NCT04693494: Effectiveness of a Training Program for Parents of Babies in Their First Year of Life to Achieve Motor Milestones |
|
|
| Completed | N/A | 82 | Europe | Training program | Universidad San Jorge | Term, Healthy, Motor Delay, Development, Infant | 12/20 | 01/23 | | |
Díez, Beatriz Cano |
NCT04693494: Effectiveness of a Training Program for Parents of Babies in Their First Year of Life to Achieve Motor Milestones |
|
|
| Completed | N/A | 82 | Europe | Training program | Universidad San Jorge | Term, Healthy, Motor Delay, Development, Infant | 12/20 | 01/23 | | |